4processed
Form 4 — Insider Transaction
Janux Therapeutics, Inc.(JANX)
Filing Date
June 2, 2026
Accepted
June 2, 2026
Accession No.
0002069239-26-000005
CIK
0001817713
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | Other | 4.1K | $14.029 | — | 75.9K | Common Stock | Jun 2, 2026 |